Detalhe da pesquisa
1.
A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2.
Allergy
; 77(1): 243-257, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34496033
2.
TLR7 Signaling Shapes and Maintains Antibody Diversity Upon Virus-Like Particle Immunization.
Front Immunol
; 12: 827256, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-35126381
3.
AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate.
Vaccines (Basel)
; 9(4)2021 Apr 19.
Artigo
Inglês
| MEDLINE | ID: mdl-33921677